- Home
- DFIN vs NVCR Comparison
DFIN vs NVCR Comparison
Compare DFIN & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DFIN
- NVCR
- Stock Information
- Founded
- DFIN 1983
- NVCR 2000
- Country
- DFIN United States
- NVCR Jersey
- Employees
- DFIN N/A
- NVCR N/A
- Industry
- DFIN Other Consumer Services
- NVCR Medical/Dental Instruments
- Sector
- DFIN Consumer Discretionary
- NVCR Health Care
- Exchange
- DFIN Nasdaq
- NVCR Nasdaq
- Market Cap
- DFIN 1.9B
- NVCR 1.8B
- IPO Year
- DFIN N/A
- NVCR 2015
- Fundamental
- Price
- DFIN $61.45
- NVCR $17.09
- Analyst Decision
- DFIN Strong Buy
- NVCR Buy
- Analyst Count
- DFIN 3
- NVCR 5
- Target Price
- DFIN $76.33
- NVCR $26.60
- AVG Volume (30 Days)
- DFIN 213.0K
- NVCR 885.3K
- Earning Date
- DFIN 10-31-2024
- NVCR 10-30-2024
- Dividend Yield
- DFIN N/A
- NVCR N/A
- EPS Growth
- DFIN 18.18
- NVCR N/A
- EPS
- DFIN 3.18
- NVCR N/A
- Revenue
- DFIN $802,100,000.00
- NVCR $577,738,000.00
- Revenue This Year
- DFIN $1.75
- NVCR $19.13
- Revenue Next Year
- DFIN $4.27
- NVCR $5.33
- P/E Ratio
- DFIN $19.28
- NVCR N/A
- Revenue Growth
- DFIN 1.74
- NVCR 14.63
- 52 Week Low
- DFIN $56.02
- NVCR $11.29
- 52 Week High
- DFIN $71.01
- NVCR $24.74
- Technical
- Relative Strength Index (RSI)
- DFIN 47.99
- NVCR 52.30
- Support Level
- DFIN $58.92
- NVCR $15.35
- Resistance Level
- DFIN $61.35
- NVCR $17.35
- Average True Range (ATR)
- DFIN 2.05
- NVCR 0.98
- MACD
- DFIN 0.11
- NVCR -0.06
- Stochastic Oscillator
- DFIN 58.14
- NVCR 52.41
About DFIN Donnelley Financial Solutions Inc.
Donnelley Financial Solutions Inc is a global risk and compliance solutions company. The company provides regulatory filing and deal solutions via its software-as-a-service, technology-enabled services, and print and distribution solutions to public and private companies, mutual funds, and other regulated investment firms. The company operates in four segments: Capital Markets - Software Solutions, Capital Markets - Compliance and Communications Management, Investment Companies - Software Solutions and Investment Companies - Compliance and Communications Management. Its geographical segments are the United States( US), Europe, Asia, Canada, and others, of which the US accounts for the vast majority of its total revenue.
About NVCR NovoCure Limited
NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.